MRI Can Help Distinguish Anterior Ischemic Optic Neuropathy From Optic Neuritis
Optic nerve enhancement patterns and white matter lesion distribution can guide diagnoses.
Neuromyelitis Optica
Decreased Risk for Neuromyelitis Optica Spectrum Disorder Relapse During Pregnancy
Study researchers sought to assess the effects of pregnancy on relapse pattern in patients with neuromyelitis optica spectrum disorder.
Contrasting Patterns of Gray Matter Damage Across Subtypes of MS
Investigators strove to quantify imaging patterns of central nervous system damage in MOGAD during the remission stage, and to compare it with NMOSD-AQP4 and MS.
Ventral Posterior Nucleus Role in Neuropathic Pain, Neuromyelitis Optica Spectrum Disorders
Thalamic ventral posterior nucleus volume is associated with neuropathic pain intensity in patients with neuromyelitis optica spectrum disorders.
Eculizumab Reduces Relapse Risk in Neuromyelitis Optica Spectrum Disorder
The terminal complement inhibitor eculizumab reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder (NMOSD).
Increased Pain Medication Use in Patients With Relapse of Neuromyelitis Optica Spectrum Disorder
Patients with neuromyelitis optica spectrum disorder who experience relapses use more pain medication than non-relapsing patients.
Enspryng, a Self-Administered Treatment for NMOSD, Gets FDA Approval
The FDA has approved Enspryng (satralizumab-mwge; Genentech) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
Patients With Neuromyelitis Optica at Increased Risk for Fracture
Given the limited data is available on bone health of patients with NMOSD-AQP4, researchers aimed to investigate their risk for fracture and bone loss.
Satralizumab Can Delay and Reduce Neuromyelitis Optica Spectrum Disorder Relapse Rate
Satralizumab monotherapy may reduce the risk for neuromyelitis optics spectrum disorder relapse, and has a favorable safety profile.
COVID-19 and Neuromyelitis Optica Disorder: A Need for Guidance-Based Management
Little guidance has been issued on how to manage patients with COVID-19 and coexisting neurological disorders.
- Loading...
Loading...
Next post in General Neurology
Loading... 
Loading...